Inhibitors of the tyrosine kinase EphB4. Part 4: Discovery and optimization of a benzylic alcohol series

被引:29
作者
Barlaam, Bernard [1 ]
Ducray, Richard [1 ]
Lambert-van der Brempt, Christine [1 ]
Ple, Patrick [1 ]
Bardelle, Catherine [2 ]
Brooks, Nigel [2 ]
Coleman, Tanya [2 ]
Cross, Darren [2 ]
Kettle, Jason G. [2 ]
Read, Jon [2 ]
机构
[1] AstraZeneca, Ctr Rech, ZI Pompelle, F-51689 Reims 2, France
[2] AstraZeneca, Macclesfield SK10 4TG, Cheshire, England
关键词
EphB4; kinase; Kinase inhibitor; Bis-anilinopyrimidine; RECEPTOR; ANGIOGENESIS; DOMAIN;
D O I
10.1016/j.bmcl.2011.03.009
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Optimization of our bis-anilino-pyrimidine series of EphB4 kinase inhibitors led to the discovery of compound 12 which incorporates a key m-hydroxymethylene group on the C4 aniline. 12 displays a good kinase selectivity profile, good physical properties and pharmacokinetic parameters, suggesting it is a suitable candidate to investigate the therapeutic potential of EphB4 kinase inhibitors. (C) 2011 Elsevier Ltd. All rights reserved.
引用
收藏
页码:2207 / 2211
页数:5
相关论文
共 24 条
[1]   Inhibitors of the tyrosine kinase EphB4. Part 2: Structure-based discovery and optimisation of 3,5-bis substituted anilinopyrimidines [J].
Bardelle, Catherine ;
Coleman, Tanya ;
Cross, Darren ;
Davenport, Sara ;
Kettle, Jason G. ;
Ko, Eun Jung ;
Leach, Andrew G. ;
Mortlock, Andrew ;
Read, Jon ;
Roberts, Nicola J. ;
Robins, Peter ;
Williams, Emma J. .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (21) :5717-5721
[2]   Inhibitors of the tyrosine kinase EphB4.: Part 1:: Structure-based design and optimization of a series of 2,4-bis-anilinopyrimidines [J].
Bardelle, Catherine ;
Cross, Darren ;
Davenport, Sara ;
Kettle, Jason G. ;
Ko, Eun Jung ;
Leach, Andrew G. ;
Mortlock, Andrew ;
Read, Jon ;
Roberts, Nicola J. ;
Robins, Peter ;
Williams, Emma J. .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (09) :2776-2780
[3]   Inhibitors of the tyrosine kinase EphB4. Part 3: Identification of non-benzodioxole-based kinase inhibitors [J].
Bardelle, Catherine ;
Barlaam, Bernard ;
Brooks, Nigel ;
Coleman, Tanya ;
Cross, Darren ;
Ducray, Richard ;
Green, Isabelle ;
Lambert-van der Brempt, Christine ;
Olivier, Annie ;
Read, Jon .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (21) :6242-6245
[4]   Discovery and structural analysis of Eph receptor tyrosine kinase inhibitors [J].
Choi, Yongmun ;
Syeda, Farisa ;
Walker, John R. ;
Finerty, Patrick J., Jr. ;
Cuerrier, Dominic ;
Wojciechowski, Amy ;
Liu, Qingsong ;
Dhe-Paganon, Sirano ;
Gray, Nathanael S. .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (15) :4467-4470
[5]  
DeLano W.L., 2002, The PyMOL molecular graphics system
[6]   Coot:: model-building tools for molecular graphics [J].
Emsley, P ;
Cowtan, K .
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY, 2004, 60 :2126-2132
[7]   Cytochrome P450 enzymes mechanism based inhibitors: Common sub-structures and reactivity [J].
Fontana, E ;
Dansette, PM ;
Poli, SM .
CURRENT DRUG METABOLISM, 2005, 6 (05) :413-454
[8]   A quantitative analysis of kinase inhibitor selectivity [J].
Karaman, Mazen W. ;
Herrgard, Sanna ;
Treiber, Daniel K. ;
Gallant, Paul ;
Atteridge, Corey E. ;
Campbell, Brian T. ;
Chan, Katrina W. ;
Ciceri, Pietro ;
Davis, Mindy I. ;
Edeen, Philip T. ;
Faraoni, Raffaella ;
Floyd, Mark ;
Hunt, Jeremy P. ;
Lockhart, Daniel J. ;
Milanov, Zdravko V. ;
Morrison, Michael J. ;
Pallares, Gabriel ;
Patel, Hitesh K. ;
Pritchard, Stephanie ;
Wodicka, Lisa M. ;
Zarrinkar, Patrick P. .
NATURE BIOTECHNOLOGY, 2008, 26 (01) :127-132
[9]   The soluble extracellular domain of EphB4 (sEphB4) antagonizes EphB4-EphrinB2 interaction, modulates angiogenesis, and inhibits tumor growth [J].
Kertesz, N ;
Krasnoperov, V ;
Reddy, R ;
Leshanski, L ;
Kumar, SR ;
Zozulya, S ;
Gill, PS .
BLOOD, 2006, 107 (06) :2330-2338
[10]   Novel EphB4 Monoclonal Antibodies Modulate Angiogenesis and Inhibit Tumor Growth [J].
Krasnoperov, Valery ;
Kumar, S. Ram ;
Ley, Eric ;
Li, Xiuqing ;
Scehnet, Jeffrey ;
Liu, Ren ;
Zozulya, Sergey ;
Gill, Parkash S. .
AMERICAN JOURNAL OF PATHOLOGY, 2010, 176 (04) :2029-2038